Relypsa

Relypsa develops polymeric drugs for cardiovascular, metabolic and renal diseases. Read more

Patrick Treanor's photo - President of Relypsa

President

Patrick Treanor

CEO Approval Rating

77/100

Founded:

1994

Status:

PrivateSubsidiary of Galenica AG

RELYPSA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

ZS Pharma is perceived as one of Relypsa's biggest rivals. ZS Pharma was founded in 2008 in San Mateo, California. ZS Pharma is in the Pharmaceuticals field. ZS Pharma generates $4.1M more revenue than Relypsa.

Ardelyx is Relypsa's #2 rival. Ardelyx is a Public company that was founded in 2007 in Fremont, California. Ardelyx competes in the Biotechnology field. Compared to Relypsa, Ardelyx has 277 fewer employees.

CMP Pharma is one of Relypsa's top competitors. CMP Pharma's headquarters is in Farmville, North Carolina, and was founded in 1975. CMP Pharma operates in the Pharmaceuticals industry. CMP Pharma generates 143% of Relypsa's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Heron Therapeutics a competitor of Relypsa?

Relypsa Acquisitions

No recent acquisitions found related to Relypsa

Relypsa Funding History

Since Relypsa was founded in 1994, it has participated in 7 rounds of funding. In total Relypsa has raised $447.4M. Relypsa's last funding round was on May 2016 for a total of $150.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
May 2016
$150M
Debt
Jun 2014
$35M
IPO
Nov 2013
$75.3M
-
Series C
Aug 2012
$80M
Series B
Sep 2010
$70M

Since Relypsa was founded in 1994, it has participated in 7 rounds of funding. In total Relypsa has raised $447.4M. Relypsa's last funding round was on May 2016 for a total of $150.0M

Relypsa Investments

No recent investments found related to Relypsa

Relypsa News

September 3, 2018BioPortfolio

Relypsa Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062018 Prices from USD $250

SummaryRelypsa Inc Relypsa a subsidiary of Vifor Pharma AG is a biopharmaceutical company that discov... See more »
June 5, 2018The Business Journals

Seeking trifecta against kidney disease, biotech team lines up $150 million IPO

They built and sold Ilypsa and Relypsa, now this team is prepping their latest company to ask the FDA... See more »
May 8, 2018PharmiWeb

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® ... See more »
March 22, 2018BioPortfolio

Relypsa Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250

SummaryRelypsa Inc Relypsa a subsidiary of Vifor Pharma AG is a biopharmaceutical company that discov... See more »
November 16, 2017BioPortfolio

Relypsa Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 26102017 Prices from USD $250

SummaryRelypsa Inc Relypsa a subsidiary of Vifor Pharma AG is a biopharmaceutical company that discov... See more »
November 3, 20174-traders

Relypsa Announces Presentation of New Clinical and Real-World Analyses of Veltassa��at ASN Kidney Week 2017

(4-traders.com) REDWOOD CITY, Calif., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma... See more »
October 13, 2017BioPortfolio

Relypsa Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17082017 Prices from USD $250

SummaryRelypsa Inc Relypsa a subsidiary of Vifor Pharma AG is a biopharmaceutical company that discov... See more »

Relypsa Press Releases

Social Media

Relypsa Headquarters

100 Cardinal Way

Redwood City, California94063

1-650-421-9500

Driving Directions »

Trending Companies

Relypsa Summary

ABOUT

Overview

Relypsa develops polymeric drugs for cardiovascular, metabolic and renal diseases. Relypsa was founded in 1994. Relypsa's headquarters is located in Redwood City, California, USA 94063. It has raised 447.4M in 7 rounds. The latest round was in May 201...

CEO

Relypsa's President, Patrick Treanor, currently has an approval rating of 77%. Relypsa's primary competitors are ZS Pharma, Ardelyx & CMP Pharma.

Frequently Asked Questions about Relypsa

  1. When was Relypsa founded?

    Relypsa was founded in 1994
  2. Who is Relypsa's CEO?

    Relypsa's CEO is Patrick Treanor
  3. How much revenue does Relypsa generate?

    Relypsa generates $20.9M in revenue
  4. How much funding does Relypsa have?

    Relypsa has historically raised $447.4M in funding
  1. Where is Relypsa's headquarters?

    Relypsa's headquarters is in Redwood City California, USA
  2. How many employees does Relypsa have?

    Relypsa has 406 employees
  3. What sector does Relypsa operate in?

    Relypsa is in Biotechnology
  4. Who are Relypsa's competitors?

    Relypsa's top competitors are ZS Pharma, Ardelyx, CMP Pharma